An update on the effect of sodium glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease: A systematic review of clinical trials

AI Alfayez, JM Alfallaj, MA Mobark… - Current Diabetes …, 2024 - ingentaconnect.com
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of liver disease,
specifically chronic liver disease. Type 2 diabetes (T2DM) is associated with the risk of …
被引用次数：2 相关文章

An Update on the Effect Of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Clinical Trials

AI Alfayez, JM Alfallaj, MA Mobark… - Current diabetes …, 2024 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of liver disease,
specifically chronic liver disease. Type 2 diabetes (T2DM) is associated with the risk of …

An update on the effect of sodium glucose cotransporter 2 inhibitors on non-alcoholic fatty liver disease: A systematic review of clinical trials.

AI Alfayez, JM Alfallaj, MA Mobark… - Current Diabetes …, 2023 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of liver disease,
specifically chronic liver disease. Type 2 diabetes (T2DM) is associated with the risk of …